From loss comes hope: Pediatric brain tumor treatment shows promise

Today a group of Stanford scientists who have spent the past decade unlocking the glioma's secrets are publishing data in Nature from the trial Ward joined. He was one of the first four patients with diffuse intrinsic pontine glioma or a closely related cancer affecting the spinal cord to receive immune cells engineered to fight the disease.

Read more: https://scopeblog.stanford.edu/2022/02/07/from-loss-comes-hope-pediatric-brain-tumor-treatment-shows-promise/